CADL logo

Candel Therapeutics (CADL)

Profile

Full Name

Candel Therapeutics, Inc.

Ticker Symbol

CADL

Exchange

NASDAQ

Country

United States

IPO

July 27, 2021

Indexes

Not included

Employees

38

Key Details

Price

$4.57(+0.88%)

Market cap

$215.87M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.74(-32.82% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 11, 25 HC Wainwright & Co.
Buy
Mar 14, 25 HC Wainwright & Co.
Buy
Feb 26, 25 HC Wainwright & Co.
Buy
Feb 26, 25 Canaccord Genuity
Buy
Feb 20, 25 Citigroup
Buy
Feb 19, 25 Canaccord Genuity
Buy
Feb 7, 25 B of A Securities
Buy
Dec 18, 24 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Candel Therapeutics?
  • Does Candel Therapeutics pay dividends?
  • What sector is Candel Therapeutics in?
  • What industry is Candel Therapeutics in?
  • What country is Candel Therapeutics based in?
  • When did Candel Therapeutics go public?
  • Is Candel Therapeutics in the S&P 500?
  • Is Candel Therapeutics in the NASDAQ 100?
  • Is Candel Therapeutics in the Dow Jones?
  • When was Candel Therapeutics's last earnings report?
  • When does Candel Therapeutics report earnings?
  • Should I buy Candel Therapeutics stock now?

What is the ticker symbol for Candel Therapeutics?

The ticker symbol for Candel Therapeutics is NASDAQ:CADL

Does Candel Therapeutics pay dividends?

No, Candel Therapeutics does not pay dividends

What sector is Candel Therapeutics in?

Candel Therapeutics is in the Healthcare sector

What industry is Candel Therapeutics in?

Candel Therapeutics is in the Biotechnology industry

What country is Candel Therapeutics based in?

Candel Therapeutics is headquartered in United States

When did Candel Therapeutics go public?

Candel Therapeutics's initial public offering (IPO) was on July 27, 2021

Is Candel Therapeutics in the S&P 500?

No, Candel Therapeutics is not included in the S&P 500 index

Is Candel Therapeutics in the NASDAQ 100?

No, Candel Therapeutics is not included in the NASDAQ 100 index

Is Candel Therapeutics in the Dow Jones?

No, Candel Therapeutics is not included in the Dow Jones index

When was Candel Therapeutics's last earnings report?

Candel Therapeutics's most recent earnings report was on Mar 13, 2025

When does Candel Therapeutics report earnings?

The next expected earnings date for Candel Therapeutics is May 14, 2025

Should I buy Candel Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page